As shown in Figure 6, SNHG7 overexpression was identified in cholangiocarcinoma (CHOL), colon adenocarcinoma (COAD), liver hepatocellular carcinoma (LIHC), pheochromocytoma and paraganglioma (PCPG) (|Log2fold change (FC)| cutoff >1 and P<0.01). Here, SNHG7 is linked to cholangiocarcinoma.